Intravenous Pyelogram Market by Type, Product, Application, End User, and Region - Global Opportunity Analysis and Industry Forecast, Vendor Landscape, Market Growth, Trends & Forecast 2019 – 2025
According to a new market research report published by Apsters Research “Intravenous Pyelogram Market by Type of Procedure, Application, End User, and Region - Global Opportunity Analysis and Industry Forecast, 2019 – 2025”, the global intravenous pyelogram market is expected to reach USD xxx million by 2025 from USD xxx million in 2018, at a CAGR of xx% during the forecast period.
The research study focuses on the global intravenous pyelogram market covering in-depth description, competitive scenario, product offerings of key vendors and business strategy adopted by competitors along with their SWOT analysis, revenue, sales and Porter's Five Forces Analysis.
Advances in the methods of medical imaging technology is providing growth opportunities to the key players
Over the past few years, there have been various major advances in the methods of medical imaging that have brought abundant benefits to the patients both for diagnosis as well as treatment. Some of these new imaging technologies are said to be increasingly dependent on highly sophisticated technology. Most of the doctors and healthcare professionals using these techniques believe that newer the technology, the better its effects. This belief has a major role to play in the future of intravenous pyelogram market.
Growing number of patients with urinary tract abnormalities is primarily driving the growth of this market
Growing urinary tract abnormalities and increasing number of patient suffering with kidney stones, enlarged prostate, and bladder stones, is the primary factor driving the growth of intravenous pyelogram market during the forecast period. Globally, prevalence of kidney stones is increasing due to environmental cause and genetic predisposition. Based on the statistical data, on an average 6% woman and 12% men are affected with kidney stones. Also, renal colic caused by kidney stones is commonly accompanied by other urinary disorders. This fact is likely to the major contributor to the growth of intravenous pyelogram market. However, growing adoption of computed tomography as an alternative and more advanced diagnostic technique is likely to impact the market growth during the forecast period.
The key segments of the intravenous pyelogram market report:
The intravenous pyelogram market is segmented on the basis of type of procedure, application, end user and geography. On the basis of type of procedure, the market is segmented into routine intravenous pyelogram, emergency intravenous pyelogram, and others. The application segment is divided into chronic pyelonephritis, kidney stones, renal cell carcinoma (RCC), transitional cell carcinoma (TCC), polycystic kidneys, and anatomical variations. On the basis of end user the market is segmented into hospitals, clinics, ambulatory surgery centers and others.
Enquire for detailed ToC and Sample Pages at – https://www.apstersresearch.com/request-sample/1005
North America to dominate the global Intravenous pyelogram market in 2019
Geographic breakdown and deep analysis of each of the segments mentioned above is included for North America, Europe, Asia-Pacific, and Rest of the World. North America is expected to dominate the market by holding maximum market share of the global intravenous pyelogram market. However, Asia-Pacific is expected to experience a fastest growth during the forecast period. As emerging nations are mainly focusing on improving their healthcare infrastructure, expanding into developing and under developed regions offers significant growth opportunities to the players.
Research and development activities and product launches enable the key players to enhance their market presence in the intravenous pyelogram market
The companies operating in the global intravenous pyelogram market are currently focusing on developing and advancing their existing technologies. Increasing the quality and accuracy of the exam is the major focus of the players active in the industry. In order to maintain their market position and gain significant market share, the companies adopt various organic and inorganic growth strategies such as partnerships, collaborations, agreements and expansion.
Some of the major companies profiled in the report include Allengers Medical Systems, Boston Scientific Corporation, C.R. Bard, Karl Storz and KG, Cook Medical, Coloplast Group, DirexGroup, Dornier MedTech, Olympus Corporation, Richard Wolf.